HIV Policy and Advocacy
The Latest

Clinical Trial Data Needs to Reflect the Demographics of HIV, Say Activists
A recent analysis conducted by the AIDS Treatment Activists Coalition revealed that, among HIV drug trial participants, data specific to race and sex were dramatically underreported.

This San Francisco Clinic Is Rethinking Care for People Living With HIV Experiencing Homelessness
The results: 79% of enrolled participants restarted their antiretroviral therapy within a week of enrolling, and 55% were virally suppressed after six months.

Major Conference on HIV and COVID-19 Under Fire for Putting Science Behind Paywall
For the first time, the influential annual CROI was going to postpone making its ample data available to the public. But the global HIV community swiftly protested.

Why White HIV Leadership Needs to Give Reins to Black Leaders
Racial and generational equity demand that leaders with “founder’s syndrome” transfer knowledge, relationships, and connections to new leaders in the movement to end HIV.

“It’s About Our Community”: Newly Formed Science Initiative Aims to Center the Black Experience in HIV and COVID Care
Raniyah Copeland and Stephaun Wallace explain the mission and context for the Black AIDS Institute’s new Scientific Advisory Committee.

This Week in HIV Research: The Bridges We Strive to Make
Jan. 28, 2021: COVID-19 information mistrust among Black PLWH; opportunities to intervene prior to deadly drug overdoses; we're unprepared for end-of-life needs for aging PLWH; hospitalization disparities despite universal health care.

It's Time to Incorporate Cultural Humility Into Your ASO or CBO
When organizations commit to cultural humility at the structural level through organizational accountability, HIV care can be far more responsive, community-focused, and of higher quality.

This Week in HIV Research: Are Our Priorities in the Right Place?
Dec. 10, 2020: Where the Ending the HIV Epidemic plan falls short; housing instability and HIV care incentives; financial wellbeing vs. health care access; San Diego's complex webs of HIV transmission.

4 Things We Must Do to Fight Medical Mistrust After the COVID-19 Pandemic Ends
It’s long been time to put Black experts at the center of public health, make public health visible and relatable to people, and truly understand and address medical mistrust.

PrEP and Prior Authorization: A Discriminatory Cheap Ploy
An important new analysis describes a key barrier to PrEP in the U.S., one that is almost sinister in its application predominantly in southern states.